Darkseid Steals Booster Gold's Body! #shorts #boostergold #dccomics #dcuniverse ...

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.

The National Academy of Engineering has elected Anne Aunins, a University of Virginia chemical engineering alumna and board member of the University of Virginia Engineering Foundation, to its Class of ...

The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma ...

By Mariam Sunny and Michael Erman Feb 11 (Reuters) - A U.S. Food and Drug Administration official on Wednesday defended the ...

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency’s decision, which Moderna announced in a press ...

By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...

In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner ...

The Food and Drug Administration last week refused to review Moderna’s application for its messenger RNA flu vaccine, in a ...

Moderna (NASDAQ:MRNA) executives highlighted progress on cost reductions, a ramp in international partnerships, and multiple late-stage pipeline milestones during the company’s fourth-quarter 2025 ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

PROFIT: The pharmaceutical company is expected to report a loss of $1.02 billion, or $2.54 a share, according to analysts polled by FactSet. That compares with a loss of $1.12 billion, or $2.91 a ...